Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thioredoxin reductase 2 (microbial) is an essential enzyme that maintains cellular redox homeostasis in bacteria by transferring electrons from NADPH via FAD to reduce thioredoxin—a process central to DNA synthesis/repair, antioxidant defense, and regulation of protein function through reversible oxidation-reduction reactions. Its unique structure among microbes makes it both fundamental biologically and attractive pharmacologically as an antimicrobial target due to differences from mammalian counterparts.
Inhibition of thioredoxin reductase activity, leading to disruption of cellular redox balance and oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thioredoxin Reductase 2 (microbial) (None).